HDL action on the vascular wall: is the answer NO?
- PMID: 14966559
- PMCID: PMC338271
- DOI: 10.1172/JCI21072
HDL action on the vascular wall: is the answer NO?
Abstract
Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.
Figures

Comment on
-
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.J Clin Invest. 2004 Feb;113(4):569-81. doi: 10.1172/JCI18004. J Clin Invest. 2004. PMID: 14966566 Free PMC article.
References
-
- Gordon DJ, Rifkind BM. High-density lipoprotein—the clinical implications of recent studies. N. Engl. J. Med. 1989;321:1311–1316. - PubMed
-
- Foody JM, et al. HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation. Circulation. 2000;102:III90–III94. - PubMed
-
- Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis. 1988;8:737–741. - PubMed
-
- Rubins HB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 1999;341:410–418. - PubMed
-
- Brown BG, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N. Engl. J. Med. 2001;345:1583–1592. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical